220 related articles for article (PubMed ID: 34233297)
1. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer.
Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q
Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
[TBL] [Abstract][Full Text] [Related]
3. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
Front Oncol; 2021; 11():711402. PubMed ID: 34497764
[TBL] [Abstract][Full Text] [Related]
5. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
Yin Z; Ma T; Chen S; Yu M
Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
[TBL] [Abstract][Full Text] [Related]
6. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
Cabrero-de Las Heras S; Martínez-Balibrea E
World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
[TBL] [Abstract][Full Text] [Related]
7. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
[TBL] [Abstract][Full Text] [Related]
8. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor.
Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y
Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
Li X; Zhong Q; Luo D; Du Q; Liu W
PLoS One; 2019; 14(4):e0214611. PubMed ID: 30973890
[TBL] [Abstract][Full Text] [Related]
11. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells.
Zhang Z; Tan X; Luo J; Cui B; Lei S; Si Z; Shen L; Yao H
Cancer Med; 2018 Nov; 7(11):5611-5620. PubMed ID: 30267476
[TBL] [Abstract][Full Text] [Related]
12. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
13. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses.
Lv QY; Zou HZ; Xu YY; Shao ZY; Wu RQ; Li KJ; Deng X; Gu DN; Jiang HX; Su M; Zou CL
Bioengineered; 2021 Dec; 12(1):3711-3725. PubMed ID: 34269159
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer.
Jing Y; Wang F; Zhang K; Chen Z
BMC Med Genomics; 2022 Apr; 15(1):96. PubMed ID: 35468838
[TBL] [Abstract][Full Text] [Related]
16. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
Oladipo O; Conlon S; O'Grady A; Purcell C; Wilson C; Maxwell PJ; Johnston PG; Stevenson M; Kay EW; Wilson RH; Waugh DJ
Br J Cancer; 2011 Feb; 104(3):480-7. PubMed ID: 21285972
[TBL] [Abstract][Full Text] [Related]
17. The expression and role of CXC chemokines in colorectal cancer.
Verbeke H; Struyf S; Laureys G; Van Damme J
Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma.
Wang K; Li R; Zhang Y; Qi W; Fang T; Yue W; Tian H
Int J Gen Med; 2022; 15():2283-2300. PubMed ID: 35250303
[TBL] [Abstract][Full Text] [Related]
19. Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.
Wang J; Zhang C; Chen X; Li Y; Li A; Liu D; Li F; Luo T
Transl Cancer Res; 2021 May; 10(5):2169-2187. PubMed ID: 35116536
[TBL] [Abstract][Full Text] [Related]
20. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
Front Oncol; 2019; 9():1555. PubMed ID: 32117786
[No Abstract] [Full Text] [Related]
[Next] [New Search]